| Heading: |
Blood Cancer: Diagnosis |
| Question ID: |
1744843 |
| UIN: |
16328 |
| House: |
Commons |
| Date tabled: |
2024-11-26 |
| Asking Member ID: |
5103 |
| Asking Member display name: |
Luke Taylor
|
| Asking Member handle: |
LukeTaylorLD
|
| Asking Member Twitter reference: |
@LukeTaylorLD
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the effectiveness of non-specific symptom pathways in diagnosing blood cancers in each of the last three years. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2024-12-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
1506 |
| Answering Member display name: |
Andrew Gwynne
|
| Answering Member handle: |
GwynneMP
|
| Answering Member Twitter reference: |
@GwynneMP
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
We will get the National Health Service diagnosing cancer earlier and treating it faster, including blood cancer. This is supported by NHS England’s key ambition on cancer, to meet the Faster Diagnosis Standard, which sets a target of 28 days from urgent ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |